At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Glutathionedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome
In Brief
A clinical study evaluating Glutathione for Post-polio Syndrome and 4 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
In this study, people who have symptoms of post polio will take oral glutathione supplements for three months. Their levels of fatigue, physical activity and sleep efficiency will be assessed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-polio Syndrome, Physical Activity, Depression, Pain, Sleep Disorders
CountriesUnited States
CollaboratorsPenn State University
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 2011
Enrollment StartAug 2011
Primary CompletionApr 2013
Study CompletionJul 2013
TodayJul 2026
First PostedJul 26, 2011
Enrollment StartAug 1, 2011
Primary CompletionApr 1, 2013
Study CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 14.9 years ago
Interventions
Glutathionedietary
glutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione.